Journal of Clinical Laboratory Analysis 2020

3 papers
The 2020 edition of the Journal of Clinical Laboratory Analysis featured research primarily focused on the identification and validation of biomarkers for various forms of cancer. Studies from this year explored diagnostic tools for early detection and the molecular mechanisms driving tumor progression. For instance, researchers investigated the use of clinical laboratory parameters to develop classifiers for the early detection of osteosarcoma. Other work examined the role of cdc6 as a biomarker for circulating tumor cells in lung cancer patients, highlighting a focus on improving diagnostic methods through laboratory medicine. Additionally, the journal published findings on the molecular regulation of hepatocellular carcinoma (HCC). One study detailed how the downregulation of miR-1225-5p influences the proliferation and migration of HCC cells through the NFκB signaling pathway. Prolific contributors to the journal during this period included authors such as Hui Wang, Lin Pei, and Lin-Lin Cao. Collectively, the research from this year emphasizes the integration of clinical laboratory data with molecular biology to enhance the detection and understanding of oncological diseases.

Top Research Directions

The 13 research directions with Journal of Clinical Laboratory Analysis 2020 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Quantifying Gene Expression with Real-Time PCR266.7%
2Detecting and Characterizing Low Abundance Cell Populations133.3%
3Dual Luciferase Reporter Assays for MicroRNA Target Validation133.3%
4Mapping Immune Landscapes with Multi-Parameter Flow Cytometry133.3%
5MicroRNA Mediated Post Transcriptional Gene Silencing133.3%
6MicroRNAs as Endogenous Brakes on Tumor Progression133.3%
7Overcoming the Specificity Gap in Clinical Biomarkers133.3%
8Pleiotropic Gene Regulation by MicroRNA Networks133.3%
9Quantifying Cellular Motility and Invasion In Vitro133.3%
10Resolving the Functional Ambiguity of MicroRNAs133.3%
11Spatial Localization of Nucleic Acids via In Situ Hybridization133.3%
12The Challenge of Biomarker Validation in Small Cohorts133.3%
13Virtual Biopsies via Radiomics and Molecular Biomarkers133.3%

Download all directions as CSV

Institutions

Institutions credited by Journal of Clinical Laboratory Analysis 2020 papers: a paper credits every institution named in its affiliations, once. 3 institutions share 1 credited papers.

#InstitutionPapersShare
104gjmb875 1100.0%
2Capital Medical University 1100.0%
3Sina (China) 1100.0%

Download all institutions as CSV

About this data

Papers. Journal of Clinical Laboratory Analysis 2020 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 3 papers (33.3%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Clinical Laboratory Analysis 2020”, https://lacuna.tiptreesystems.com/venue/journal-of-clinical-laboratory-analysis/2020.

Impactful Papers

Papers from Journal of Clinical Laboratory Analysis 2020 that shaped research clusters.

Influential

Papers

Title
A pilot study of cdc6 as a biomarker for circulating tumor cells in patients with lung cancer
Downregulation of miR‐1225‐5p is pivotal for proliferation, invasion, and migration of HCC cells through NFκB regulation
Novel classifiers with clinical laboratory parameters for early detection of osteosarcoma